In the spirit of the Holiday Season and goodwill towards men at this time of year, it would be most appropriate to get some great news on Kevetrin and give many, many people with cancer or going to get cancer some hope that advancements may be forthcoming from expected combo trials using special K.

I think we make enough out of B and P to make all investors happy, so K is the icing on the cake and wouldn't mind seeing that side forego some profits if it would speed up the combo trials and let the world know how devastating K may be against cancer.

IPIX could be the secret Santa this year for many thousands of as yet unknowing sufferers of conditions our products will cure. For them, and for us, 2018 may be the year of the decade.